This was the stock's second consecutive day of gains.

Truist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the ...

Influence Media Partners (“Influence Media” or “Influence”) — a leading music and entertainment company focused on partnering with and investing in to ...

The impact of the Fed's combined 1% rate reduction over the last several months is already filtering through the banking ...

Truist raised the firm’s price target on Tesla (TSLA) to $373 from $351 but keeps a Hold rating on the shares. The company’s Q4 results saw ...

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...

Meta's earnings call is today at 5 pm ET. META stock heads into the report up 15% YTD. Analysts are focused on AI ...

Fintel reports that on January 29, 2025, Truist Securities initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a ...

"I think the market can live with where rates are now, as long as the 10-year rate is stable," said Keith Lerner, co-chief investment officer at Truist Advisory Services, in a call following the Fed ...

As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...

Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of Sysco Corp (NYSE:SYY) and lowered the price ...